Revision as of 06:15, 4 October 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'DrugBank_Ref', 'ChEBI_Ref') per [[WP:CHEMVALID|Chem/Dr← Previous edit | Revision as of 13:14, 21 December 2011 edit undoChemNerd (talk | contribs)Extended confirmed users17,568 editsNo edit summaryNext edit → | ||
Line 51: | Line 51: | ||
{{Stimulants}} | {{Stimulants}} | ||
{{DEFAULTSORT:Dimethylmethcathinone, 3,4-}} | |||
] | ] | ||
Revision as of 13:14, 21 December 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C12H17NO |
Molar mass | 191.269 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
3,4-Dimethylmethcathinone (3,4-DMMC) is a stimulant drug first reported in 2010 as a designer drug analogue of mephedrone, apparently produced in response to the banning of mephedrone, following its widespread abuse in many countries in Europe and around the world.
See also
References
This drug article relating to the nervous system is a stub. You can help Misplaced Pages by expanding it. |